A 52-year-old patient with chronic kidney disease presents with significant bilateral pitting edema, blood pressure of 160/100 mmHg, and elevated creatinine levels. The patient also has hyperkalemia of 5.8 mEq/L and reports fatigue and shortness of breath. Which nursing intervention is the priority to address the patient's current condition?

C) Administer a loop diuretic as prescribed to reduce edema.

A) Administer a potassium-binding resin to reduce hyperkalemia.

B) Initiate fluid restriction to manage fluid overload.

C) Administer a loop diuretic as prescribed to reduce edema.

D) Provide oxygen therapy to alleviate shortness of breath.

A patient with chronic kidney disease is experiencing acute kidney injury characterized by significant bilateral pitting edema, crackles in the lungs, elevated blood pressure, and hyperkalemia. What is the priority nursing intervention for this patient?

A) Administer a loop diuretic to reduce fluid overload.

B) Place the patient on a potassium-restricted diet.

C) Initiate dialysis to rapidly remove excess potassium.

D) Adjust the antihypertensive medication to better control blood pressure.

A patient with chronic kidney disease and fluid overload is receiving furosemide therapy. After 24 hours, the patient's potassium level is 6.1 mEq/L. Which of the following interventions should the nurse prioritize to address the patient's hyperkalemia and prevent cardiac complications?

A) Administer calcium gluconate intravenously

B) Increase the dose of furosemide to promote potassium excretion

C) Encourage the patient to eat potassium-binding foods

D) Restrict the patient's fluid intake

A patient with chronic kidney disease and fluid overload is being treated with furosemide. The patient now presents with hyperkalemia, elevated blood pressure, and an improvement in edema. Which of the following should the nurse prioritize in the management of this patient?

B) Administer calcium gluconate and insulin with glucose to address hyperkalemia.

A) Increase the dose of furosemide to enhance diuresis.

B) Administer calcium gluconate and insulin with glucose to address hyperkalemia.

C) Adjust antihypertensive medication to better control blood pressure.

D) Initiate dialysis immediately to manage fluid overload and hyperkalemia.

A patient with chronic kidney disease presents with hyperkalemia and metabolic acidosis. The healthcare team has initiated treatment with sodium bicarbonate and a beta-blocker. What is the primary nursing intervention to monitor for potential complications related to these treatments?

A) Monitor the patient's heart rate and blood pressure closely.

B) Administer diuretics to prevent fluid overload.

C) Increase the patient's dietary potassium intake.

D) Encourage the patient to increase fluid intake.

A patient with chronic kidney disease presents with hyperkalemia and metabolic acidosis. The healthcare team decides to administer sodium bicarbonate. What is the primary reason for this intervention in the context of the patient's condition?

C) To correct metabolic acidosis and shift potassium intracellularly

A) To directly lower serum potassium levels by renal excretion

B) To improve cardiac function by increasing serum calcium levels

C) To correct metabolic acidosis and shift potassium intracellularly

D) To enhance the action of beta-blockers in controlling hypertension

A patient with chronic kidney disease and metabolic acidosis is being monitored for fluid overload. Despite improvements in potassium levels, the serum bicarbonate remains low. The patient's blood pressure has improved with a beta-blocker, but there are signs of fluid retention. What is the nurse's priority intervention to address the patient's current condition?

C) Consult with the healthcare provider about initiating diuretic therapy.

A) Increase the dosage of the beta-blocker to further manage blood pressure.

B) Administer sodium bicarbonate to correct the metabolic acidosis.

C) Consult with the healthcare provider about initiating diuretic therapy.

D) Encourage the patient to increase fluid intake to improve hydration.

A patient with chronic kidney disease and recent metabolic acidosis presents with mild peripheral edema and pulmonary crackles. The healthcare team is considering the cautious use of diuretics. What is the priority nursing action in this scenario?

A) Administer the prescribed diuretic and monitor the patient's blood pressure closely.

B) Increase the patient's fluid intake to prevent dehydration from diuretic use.

C) Educate the patient on reducing dietary potassium intake.

D) Prepare the patient for an immediate hemodialysis session.

A patient with mixed metabolic acidosis and hyperkalemia, managed with sodium bicarbonate and a low-dose loop diuretic, continues to exhibit mild peripheral edema and exertional dyspnea. Which nursing intervention should be prioritized to address the patient's current condition?

B) Monitor daily weights and assess for signs of fluid overload.

A) Encourage increased oral fluid intake to promote diuresis.

B) Monitor daily weights and assess for signs of fluid overload.

C) Administer supplemental oxygen to maintain oxygen saturation above 98%.

D) Educate the patient on reducing dietary potassium intake.

A patient with persistent metabolic acidosis, hyperkalemia management, and signs of fluid overload is being treated with a low-dose loop diuretic. Which nursing intervention is most appropriate to monitor for potential complications associated with this treatment?

B) Assess for symptoms of hypokalemia, such as muscle weakness and cardiac arrhythmias.

A) Monitor blood glucose levels and assess for signs of hyperglycemia.

B) Assess for symptoms of hypokalemia, such as muscle weakness and cardiac arrhythmias.

C) Encourage increased fluid intake to prevent dehydration.

D) Evaluate for signs of skin breakdown due to fluid shifts.

Acute Kidney Injury and Chronic Kidney Disease - Nursing Case Study

Pathophysiology

• Primary mechanism (Acute Kidney Injury): Sudden reduction in kidney function often due to decreased blood flow, direct damage to the kidneys, or obstruction, leading to the accumulation of waste products and fluid imbalance.

• Secondary mechanism (Chronic Kidney Disease): Progressive loss of kidney function over months or years, primarily due to long-standing conditions like hypertension or diabetes, resulting in glomerular damage and fibrosis.

• Key complication: Both conditions can lead to electrolyte imbalances, hypertension, and increased risk of cardiovascular events, significantly impacting overall health and necessitating prompt intervention.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, stage 3 chronic kidney disease

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and swelling in legs

• Key symptoms: Fatigue, nausea, shortness of breath, pitting edema in lower extremities

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

Initial Assessment Findings:

Upon further assessment, the patient exhibits significant bilateral pitting edema in the lower extremities, rated as 3+ on a scale of 1 to 4, indicating substantial fluid overload. The patient also reports feeling increasingly fatigued over the past week, which has impacted his ability to perform daily activities, including his work as a construction worker. Auscultation reveals crackles at the bases of both lungs, suggesting potential fluid accumulation in the lungs, which correlates with his reported shortness of breath. These findings, combined with a blood pressure of 160/100 mmHg, suggest poorly controlled hypertension, likely exacerbating his chronic kidney disease and contributing to the acute kidney injury.

To further evaluate the patient's condition, laboratory tests are ordered, including serum electrolytes, blood urea nitrogen (BUN), creatinine, and a complete blood count. Initial lab results indicate elevated creatinine levels at 3.5 mg/dL, up from a baseline of 1.8 mg/dL, suggesting worsening renal function. BUN is also elevated at 46 mg/dL. Electrolyte imbalances are present, with hyperkalemia noted at 5.8 mEq/L, potentially posing a risk for cardiac complications. Hemoglobin levels are slightly low at 11 g/dL, which may contribute to the patient's fatigue and requires close monitoring given his renal impairment.

These findings necessitate immediate intervention to address the acute kidney injury and prevent further complications. The healthcare team considers initiating diuretic therapy to manage fluid overload while carefully monitoring electrolyte levels to prevent further imbalance. Additionally, adjustments to his antihypertensive regimen may be required to better control his blood pressure and reduce strain on the kidneys. This stage of the patient's journey highlights the need for integrated care strategies to manage both acute and chronic aspects of kidney disease, emphasizing the importance of regular monitoring and timely modification of treatment plans.

Section 2

Following the initial interventions, the healthcare team closely monitors the patient's response to treatment. Diuretic therapy is initiated with furosemide to address the fluid overload, aiming to reduce the patient's pulmonary congestion and peripheral edema. Over the next 24 hours, the patient experiences increased urine output, and a subsequent assessment reveals a decrease in bilateral pitting edema to 2+ on a scale of 1 to 4. Auscultation of the lungs shows some improvement, with diminished crackles at the bases, and the patient reports slightly improved breathing comfort. These changes indicate a positive response to diuretics, suggesting effective management of fluid overload.

However, follow-up lab results reveal a concerning trend. While creatinine levels have slightly decreased to 3.2 mg/dL, indicating initial improvement in kidney function, the patient's potassium level has risen to 6.1 mEq/L, exacerbating the risk of cardiac complications such as arrhythmias. The healthcare team recognizes the need for immediate intervention to address the hyperkalemia. Continuous cardiac monitoring is implemented, and treatment with calcium gluconate and insulin with glucose is considered to stabilize cardiac function and facilitate intracellular potassium shift.

The patient's blood pressure remains elevated at 158/98 mmHg despite adjustments to his antihypertensive regimen, indicating persistent hypertension that requires further investigation and possible modification of medications. The need for a nephrology consultation becomes apparent to balance the management of his chronic kidney disease with the acute challenges presented by the current complications. This stage of the patient's journey emphasizes the complexity of managing intertwined chronic and acute conditions, necessitating a comprehensive approach that anticipates potential complications while optimizing current treatment strategies.

Section 3

As the healthcare team continues to manage the patient's condition, new diagnostic results reveal further insights into his clinical status. An electrocardiogram (ECG) is conducted due to the elevated potassium levels, and it shows peaked T waves, a common sign of hyperkalemia, which underscores the urgency of correcting the electrolyte imbalance to prevent severe cardiac events. Concurrently, a repeat set of laboratory tests is performed to monitor his renal function and electrolyte status. While the patient's creatinine remains stable at 3.2 mg/dL, indicating no further acute deterioration of kidney function, the serum bicarbonate level is noted to have decreased to 18 mEq/L, suggesting the development of metabolic acidosis.

The healthcare team decides to initiate treatment with sodium bicarbonate to address the metabolic acidosis, aiming to improve the acid-base balance and reduce the risk of further complications. Additionally, given the patient's persistent hypertension and the need for careful medication titration, a beta-blocker is added to his regimen to provide better blood pressure control while considering the renal implications. The nephrologist's consultation emphasizes the importance of balancing electrolyte management with the prevention of fluid overload, especially in the context of the patient's chronic kidney disease.

These developments highlight the intricate interplay between the patient's acute and chronic conditions, requiring vigilant monitoring and timely interventions. The team remains focused on preventing cardiac complications while also stabilizing the patient's renal function and addressing his hypertensive state. This stage of the patient's journey sets the stage for potential improvements in his overall condition, provided that the multidisciplinary team continues to adapt their strategies based on the evolving clinical picture.

Section 4

As the healthcare team continues to monitor the patient, new diagnostic results reveal a concerning development. The latest laboratory tests indicate that the patient's potassium levels have decreased to 5.8 mEq/L from the previous 6.4 mEq/L, reflecting a positive response to the initial interventions. However, the serum bicarbonate, despite the administration of sodium bicarbonate, remains low at 19 mEq/L, indicating persistent metabolic acidosis. This situation necessitates a reassessment of the current treatment strategy to effectively manage the acid-base imbalance. Additionally, the patient's blood pressure has improved slightly with the introduction of the beta-blocker, now reading at 148/92 mmHg, down from earlier hypertensive levels, yet it remains above the target range for optimal renal protection.

Vital signs show that the patient is afebrile, with a heart rate of 88 bpm and respiratory rate at 20 breaths per minute. Oxygen saturation is stable at 96% on room air. Despite the modest improvements, the patient reports feeling fatigued and has mild shortness of breath on exertion, raising concerns about underlying fluid overload or progressing heart failure. Physical examination reveals mild peripheral edema and some pulmonary crackles on auscultation, suggesting fluid retention, likely compounded by the chronic kidney disease and recent interventions.

These findings prompt the healthcare team to refine their approach. The nephrologist recommends considering the cautious use of diuretics to address the fluid overload while continuing to closely monitor renal function and electrolytes. The multidisciplinary team plans to intensify their efforts to balance the delicate interplay of managing cardiac risk, fluid status, and renal function. The patient is scheduled for a follow-up with repeat labs and a potential echocardiogram to assess cardiac function in light of the new symptoms. These steps are critical in moving towards stabilizing the patient's condition and preventing further complications as his clinical journey unfolds.

Section 5

Following the initial reassessment and intervention, the healthcare team closely monitors the patient for any changes in condition. The next set of laboratory results reveals a mixed picture. The patient's serum potassium levels have further decreased to 5.2 mEq/L, indicating continued improvement in hyperkalemia management. However, the serum bicarbonate remains stubbornly low at 18 mEq/L, revealing ongoing metabolic acidosis despite sodium bicarbonate supplementation. The nephrologist notes that this persistent acidosis may exacerbate renal function decline and contribute to muscle fatigue and respiratory distress.

Clinically, the patient's blood pressure has shown slight improvement, now reading 142/88 mmHg, yet it still hovers above the ideal target for renal protection. The patient's symptoms of fatigue and exertional shortness of breath persist, with mild peripheral edema and pulmonary crackles still present. Given these findings, the decision is made to cautiously introduce a low-dose loop diuretic. The aim is to alleviate fluid retention while minimizing potential adverse effects on renal function. The team emphasizes the need for vigilant monitoring of electrolyte levels and renal parameters post-diuretic initiation.

In response to the interventions, the patient's respiratory rate has decreased to 18 breaths per minute, and oxygen saturation remains stable at 96% on room air, suggesting some improvement in respiratory effort. However, the patient reports no significant change in energy levels or dyspnea with exertion. An echocardiogram is performed, revealing mild left ventricular hypertrophy and an ejection fraction slightly below normal, supporting the concern of underlying cardiac involvement. These findings underscore the complexity of the patient's condition, necessitating a carefully coordinated approach to managing the intertwined challenges of cardiac and renal health. The healthcare team plans to adjust the treatment strategy based on these findings, with the goal of optimizing cardiac function and preventing further renal deterioration.